
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
VIDEO: The lesions appear oval with trailing edge scale. Note the the pattern and distribution in the video interview; what's your diagnosis?